PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Drug-resistance fears for deadly fungal disease

2011-05-08
(Press-News.org) Deadly human fungal infections caused by certain strains of Aspergillus fungi appear to be developing resistance to current drug treatments at an alarming rate, say scientists.

University of Manchester researchers, working with colleagues in Newark, USA, have developed a new test that can not only better diagnose Aspergillus infection, but can also spot signs of antifungal resistance to azoles – the class of drugs used to treat patients with aspergillosis.

Using the new test, which uses direct molecular detection rather than culturing the fungus in a Petri dish, the team found that 55% of aspergillosis patients had telltale signs known as 'markers' that indicated they had developed resistance to azoles. The findings compare to resistance rates of 28% carried out by the team just two years ago using traditional culturing methods.

Furthermore, the study – published in the prestigious US journal Clinical Infectious Diseases – discovered azole-resistance markers in three-quarters of the small number of aspergillosis patients (eight) whom had never been treated with an azole, suggesting widespread dissemination of resistance.

"Aspergillus significantly worsens asthma symptoms and causes life-threatening infections in those with long-term lung infections or damaged immune systems, such as chemotherapy and transplant patients or people with HIV," said David Denning, Professor of Medicine and Medical Mycology at The University of Manchester and Director of the National Aspergillosis Centre at the University Hospital of South Manchester NHS Foundation Trust.

"Using an ultrasensitive, real-time test for Aspergillus, similar to the method used to diagnose HIV, MRSA and influenza, we have directly detected azole resistance in people with aspergillosis, without first culturing the fungus in a dish. The presence of Aspergillus was detected in many more samples than using traditional culture methods, and 55% were found to contain azole-resistance markers.

"This is an extraordinarily high rate of resistance, possibly related to fungicide use in agriculture – more than a third of 'pesticides' used by UK farmers are azoles – and long treatment courses in patients, so the findings have major implications for the sustainability of azoles for human antifungal therapy."

The azoles itraconazole (Johnson & Johnson), voriconazole (Pfizer) and posaconazole (Merck) have annual sales of more than $1bn annually. Conventional diagnosis of aspergillosis is limited by poor culture yield, and so the true frequency of azole resistance has been unclear.

In this latest study, the researchers analyzed phlegm from patients with allergic and chronic lung disease caused by Aspergillus and found that almost twice the proportion of individuals tested had resistance markers in their sample compared to a Petri dish (or culture) study carried out by the team in 2008/9.

Professor Denning added: "Not only is molecular testing much more sensitive than conventional culture for diagnosis, but it enables testing for resistance, which until now has been impossible if cultures are negative. Given the rising frequency of resistance in Aspergillus in northern Europe, China and the United States, this study provides key data for doctors to shift antifungal therapy in the face of resistance."

###

Notes for editors:

A copy of the paper, Denning DW, Park S, Lass-Florl C, Fraczek MG, Kirwan M, Gore R, Smith J, Bueid A, Bowyer P, Perlin DS. High frequency triazole resistance found in non-culturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 2011;52:1123-9, is available on request.

A copy of the 2009 study, Bueid A, Howard SJ, Moore CB, Richardson MD, Harrison E, Bowyer P, Denning DW. Azole antifungal resistance in Aspergillus fumigatus - 2008 and 2009. J Antimicrob Chemother 2010;65:2116-8, is also available.

The primary molecular detection test is Myconostica's MycAssay Aspergillus, commercialized through Myconostica, a University of Manchester spin-out company, founded by Professor David Denning.

Further information concerning Aspergillus and aspergillosis can be found on www.aspergillus.org.uk

END



ELSE PRESS RELEASES FROM THIS DATE:

Is nuclear power fair for future generations?

2011-05-08
The recent nuclear accident in Fukushima Daiichi in Japan has brought the nuclear debate to the forefront of controversy. While Japan is trying to avert further disaster, many nations are reconsidering the future of nuclear power in their regions. A study by Behnam Taebi from the Delft University of Technology, published online in the Springer journal Philosophy & Technology, reflects on the various possible nuclear power production methods from an ethical perspective: If we intend to continue with nuclear power production, which technology is most morally desirable? On ...

NRL scientists achieve high temperature milestone in silicon spintronics

NRL scientists achieve high temperature milestone in silicon spintronics
2011-05-08
(WASHINGTON) -- Researchers in the Materials Science and Technology division of the Naval Research Laboratory have recently demonstrated electrical injection, detection and precession of spin accumulation in silicon, the cornerstone material of modern device technology, at temperatures up to 225 degrees Celsius. These results provide the first demonstration that spin accumulation in Si is viable as a basis for practical devices which meet the operating temperatures specified for commercial (85˚C), industrial (100˚C) and military (125˚C) applications. This ...

Pan American Metals of Miami Precious Metals Offer Investors Safe Haven from Inflation Fears in Medium to Long Term

2011-05-08
Pan American Metals of Miami (PAMOM), continues to provide opportunities for investment in the bullion markets. "Precious metals are tried and tested and provide investors with a safe alternative to low interest rates and decreasing currency values," says Bill Hionas, CEO of PAMOM. PAMOM deals in four precious metals; silver, gold, platinum and palladium. The current market is showing dips in all precious metal prices, providing savvy investors with a perfect opportunity to buy. "Long-term predictions remain optimistic for the precious metals market, ...

Worm discovery could help 1 billion people worldwide

Worm discovery could help 1 billion people worldwide
2011-05-08
Scientists have discovered why some people may be protected from harmful parasitic worms naturally while others cannot in what could lead to new therapies for up to one billion people worldwide. Parasitic worms are a major cause of mortality and morbidity affecting up to a billion people, particularly in the Third World, as well as domestic pets and livestock across the globe. Now, University of Manchester researchers have, for the first time, identified a key component of mucus found in the guts of humans and animals that is toxic to worms. "These parasitic worms ...

LateRooms.com - Enjoy Vatican Museums Under The Stars in Rome

2011-05-08
Anyone keen to see an age-old landmark from a different perspective should take advantage of the Vatican Museums Under The Stars experience in Rome. As the name suggests, it allows people to visit the attraction after sunset, with the first session taking place on May 6th. The activity, which sees the Vatican Museums staying open until 23:00 local time, is available every Friday from then on until October 28th 2011. In a statement, director of the venue Antonio Paolucci remarked: "The Pope, as the bishop of Rome, wishes to offer the most beautiful works of ...

Can one model the social deficits of autism and schizophrenia in animals?

2011-05-08
Philadelphia, PA - 5 May 2011 - The use of animal models to study human disease is essential to help advance our understanding of disease and to develop new therapeutic treatments. Social deficits are common in several psychiatric disorders, including autism spectrum disorders and schizophrenia. Individuals with severe social dysfunction can experience significant difficulties with everyday functioning. Oxytocin and vasopressin are hormones that play key roles in emotional and social behaviors and bonding. Oxytocin has been suggested as a treatment to improve social ...

LateRooms.com - Animal Collective to Play at Milan's Discoteca Alcatraz

2011-05-08
Experimental band Animal Collective are set to play a gig in Milan later this month, bringing their inimitable blend of folk and psychedelic noise to the city. The group will take the stage on May 25th and no doubt play plenty of tunes from their most recent record Merriweather Pavilion, arguably their most critically and commercially successful album. Animal Collective's live line-up is in a constant state of flux, but key members are Avey Tare, Deakin, Geologist and Panda Bear, who has received a lot of praise for his recent solo work. The Baltimore group are ...

Families need to know more about feeding tubes for elderly dementia patients

2011-05-08
PROVIDENCE, R.I. [Brown University] — Despite evidence that feeding tubes do not improve survival rates or quality of life for elderly patients with advanced dementia, their frequency of use varies widely across the states. A new survey of family members finds that discussions surrounding the decision to place feeding tubes surgically are often inadequate. Advanced dementia is a terminal illness that often affects a patient's ability to eat. In prior research, Joan Teno, professor of community health at Brown University, has documented a striking variation in feeding ...

When the lungs come under pressure

When the lungs come under pressure
2011-05-08
Patients with pulmonary arterial hypertension struggle with severe symptoms, which include shortness of breath, exhaustion and a lack of vitality. Moreover, the disease, which is more common in women, often claims the patient's life within a few years of its development. The currently available methods of treatment can slow down the progression of the disease and improve the symptoms; a cure, however, has thus far been unavailable. Scientists from the Max Planck Institute for Heart and Lung Research and Giessen University have now succeeded - for the first time in an animal ...

eQuoteMD Releases a Comprehensive Guide on What Doctors Need to Know When Purchasing Medical Malpractice Insurance

2011-05-08
As part of an ongoing commitment to empower physicians who purchase medical malpractice insurance, eQuoteMD.com is a releasing a comprehensive white paper delineating the most important topics and factors associated with a doctor's decisions when purchasing and maintaining medical malpractice insurance coverage. This exposition into the world of physician's liability coverage will serve to educate medical professionals who must make important decisions about this type of insurance in an effort to protect the practice's they have built. This literary resource will assist ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] Drug-resistance fears for deadly fungal disease